ABL

Molecular diagnostic assays, sequencing analysis software and specimen collection kits for clinical labs, researchers and hospitals

Woippy, FranceFounded 1900abldiagnostics.comWebsite technologies

+ Add to sales board

Highlights

  • Hiring9 open roles
  • New on EvolcAdded 2026-10-24

About ABL

ABL Diagnostics develops, manufactures and sells molecular biology assays for PCR-based pathogen detection and DNA-sequencing genotyping, along with analysis software, specimen collection kits and the Nadis electronic medical record system. Its products address infectious diseases including HIV, SARS-CoV-2, tuberculosis and viral hepatitis.

Customers include academic clinical pathology laboratories, private reference laboratories, researchers and hospitals. The company sells worldwide through its sales team and exclusive distributors; its molecular biology products generate recurring revenue.

ABL Diagnostics is headquartered in Woippy, France. Products are produced or assembled in laboratories in Marseille and in its parent company's facilities in Luxembourg. Its activities have also been carried out in the United States through a wholly owned subsidiary since 2019.

Product: Molecular diagnostic assays, sequencing genotyping solutions, analysis software, specimen collection kits and an electronic medical record system.

Public tenders won

2 tenders won since 1 Jan 2024 from 2 public buyers in France, worth €500k as awarded. From EU award notices (TED) that name ABL by its registry number.

  • 8 Jan 2025 GHT de la Guadeloupe (Cellule marchés) · La consultation a pour objet « FOURNITURE DE REACTIFS ET CONSOMMABLES POUR TECHNIQUES DE LABORATOIRE (1) », pour le compte du CHUG établissement membre du Groupement Hospitalier de Territoire de la Guadeloupe (GHT notice
  • 3 May 2024 CHU MONTPELLIER · Droit d?utilisation, maintenance du logiciel et de ses interfaces et prestations associées du logiciel Nadis réalisées exclusivement par la société ABL Diagnostics et hébergement du logiciel pour les membres du réseau du COREVIH OCCITANIE · €500k notice

Open tenders like these →

Jobs at ABL (9)

ABL is hiring for 9 roles, mostly in customer support, based in Évry-Courcouronnes, Marseille and Paris. 2 are remote.

Companies hiring like ABL

More biotech & pharma companies

  • Acticor Biotech

    Clinical-stage biopharma developing glenzocimab, an antithrombotic antibody fragment for acute ischemic stroke patients
    Paris, FranceBiotech & pharmaFounded 20131 open job
    New on Evolc
  • Ademtech

    Magnetic particles and molecular diagnostic kits for IVD, life sciences and forensic laboratories
    Merignac, FranceBiotech & pharmaFounded 2000
    New on Evolc
  • Adocia

    Develops clinical-stage treatments for diabetes and obesity for patients with metabolic diseases
    Lyon, FranceBiotech & pharmaFounded 2006
    New on Evolc
  • Adragos Pharma

    Contract development and manufacturing for pharma and biotech clients in Europe, Japan and North America
    FranceBiotech & pharma31 open jobs
  • Advesya

    Clinical-stage biotech developing IL-1RAP-targeted CAR T-cell and ADC treatments for cancer and autoimmune diseases
    Paris, FranceBiotech & pharmaFounded 2020
    New on Evolc
  • Aelis Farma

    Develops CB1-targeted drug candidates for people with cannabis-related disorders and cognitive deficits
    Pessac, FranceBiotech & pharmaFounded 2013
    New on Evolc

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Forms

  • Contact Form 7High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Hosting

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.